Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
-28.00%
NET PROFIT MARGIN AVG 20Y
-34.35%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Achieve Life Sciences, Inc.
Market Cap
$735.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$737.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$740.76M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3758.80%
5Y Avg
-9679.73%
Market Cap
$720.01M
Net Profit Margin
-38.98%
TTM Avg
-18.01%
3Y Avg
-10.19%
5Y Avg
-2.91%
Market Cap
$718.54M
Net Profit Margin
5.93%
TTM Avg
9.51%
3Y Avg
5.53%
5Y Avg
9.43%
Market Cap
$717.52M
Net Profit Margin
-170055.93%
TTM Avg
-70304.07%
3Y Avg
-35619.60%
5Y Avg
-24164.90%
Market Cap
$713.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$763.85M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$771.14M
Net Profit Margin
1.92%
TTM Avg
0.94%
3Y Avg
-28.83%
5Y Avg
-18.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | $735.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Faeth Therapeutics, Inc. (FTH)vs › | $737.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Candel Therapeutics, Inc. (CADL)vs › | $740.76M | 0.00% | 0.00% | -3758.80% | -9679.73% |
| Cytek Biosciences, Inc. (CTKB)vs › | $720.01M | -38.98% | -18.01% | -10.19% | -2.91% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $718.54M | 5.93% | 9.51% | 5.53% | 9.43% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $717.52M | -170055.93% | -70304.07% | -35619.60% | -24164.90% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $713.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Design Therapeutics, Inc. (DSGN)vs › | $763.85M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mesa Laboratories, Inc. (MLAB)vs › | $771.14M | 1.92% | 0.94% | -28.83% | -18.64% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $779.56M | -147.38% | -372.93% | -22199.44% | -19748.48% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | -324.65% |
| 2016-03-31 | -126.09% |
| 2015-12-31 | -28.59% |
| 2015-09-30 | -67.54% |
| 2015-06-30 | -149.32% |
| 2015-03-31 | -328.75% |
| 2014-12-31 | -100.51% |
| 2014-09-30 | -102.17% |
| 2014-06-30 | -142.32% |
| 2014-03-31 | -73.62% |
| 2013-12-31 | -77.62% |
| 2013-09-30 | -101.95% |
| 2013-06-30 | -132.81% |
| 2013-03-31 | -131.93% |
| 2012-12-31 | -41.95% |
| 2012-09-30 | -90.11% |
| 2012-06-30 | -173.53% |
| 2012-03-31 | -521.28% |
| 2011-12-31 | -774.19% |
| 2011-09-30 | 380.75% |
| 2011-06-30 | -346.05% |
| 2011-03-31 | -253.96% |
| 2010-12-31 | -119.97% |
| 2010-09-30 | -141.24% |
| 2010-06-30 | 9.05% |
| 2010-03-31 | -64.77% |
| 2009-12-31 | 15.20% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | -24.62% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 25.01% |
| 2007-09-30 | -142.36% |
| 2007-06-30 | -182.30% |
| 2007-03-31 | -63.86% |
| 2006-12-31 | -118.99% |
| 2006-09-30 | -127.61% |
| 2006-06-30 | -65.69% |
| 2006-03-31 | -131.00% |
| 2005-12-31 | -0.04% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | -2.02% |
| 2004-09-30 | -4529.27% |
| 2004-06-30 | -6781.23% |
| 2004-03-31 | -9996.03% |
| 2003-12-31 | -1.52% |
| 2003-09-30 | -6319.63% |
| 2003-06-30 | -10191.35% |
| 2003-03-31 | -9097.38% |
| 2002-12-31 | 847.82% |
| 2002-09-30 | -3147.61% |
